Concepedia

Author

David R. Macdonald

Western University

Also Known As

D MacDonald, D Macdonald, D R MacDonald, D R Macdonald, D. MacDonald, D. Macdonald, D. R. MacDonald, D. R. Macdonald, D.R. MacDonald, D.R. Macdonald

139

Publications

14K

Citations

40

H-Index

63

Concepts

All Affiliations

Western UniversityOttawa Regional Cancer FoundationVictoria HospitalUniversity of California, San FranciscoLondon Cancer
DR

About

David R. Macdonald is an author at Western University specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

28

9.7K

2

Health Sciences

13

13

5.2K

3

Engineering

2

2

3.8K

4

Social Sciences

2

2

96

5

Cell Biology

1

1

1.6K

David R. Macdonald

×

46

Publications

12.1K

Citations

32

H-Index

YearCitations

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Patrick Y. Wen, David R. Macdonald, David A. Reardon,

Journal of Clinical Oncology

2010

3.7K

Response criteria for phase II studies of supratentorial malignant glioma.

David R. Macdonald, T L Cascino, S. Clifford Schold,

Journal of Clinical Oncology

1990

2.4K

Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas

J. Gregory Cairncross, Keisuke Ueki, Magdelena C. Zlatescu,

JNCI Journal of the National Cancer Institute

1998

1.6K

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Yasushi Ino, Rebecca A. Betensky, Magdalena C. Ƶlatescu,

PubMed

2001

435

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults

Patrick Y. Wen, Martin J. van den Bent, Gilbert Youssef,

Journal of Clinical Oncology

2023

363

Supratentorial anaplastic gliomas in adults

Michael J. Winger, David R. Macdonald, J. Gregory Cairncross

Journal of neurosurgery

1989

299

Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatment

Laurie E. Gaspar, Barbara J. Fisher, David R. Macdonald,

International Journal of Radiation Oncology*Biology*Physics

1992

295

Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma

Michael Weller, Thierry Gorlia, J. G. Cairncross,

Neurology

2011

291

End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria

Martin J. van den Bent, Michael A. Vogelbaum, Patrick Y. Wen,

Journal of Clinical Oncology

2009

240

Association of<i>MGMT</i>Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide

Erica H. Bell, Barbara J. Fisher, David R. Macdonald,

JAMA Oncology

2018

198

Page 1